Boston Scientific shells out $500mm up front for Augmenix
- Implantable Devices
- Payment Includes Cash
- Acquisition of Private Biotech
- Includes Earnout
- Full Acquisition
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.